Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $477.94 | 5 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $461.41 | 4 | $0 (2023) |
| GlaxoSmithKline, LLC. | $16.53 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $16.53 | 1 | GlaxoSmithKline, LLC. ($16.53) |
| 2023 | $124.46 | 1 | Novo Nordisk Inc ($124.46) |
| 2022 | $237.67 | 2 | Novo Nordisk Inc ($237.67) |
| 2021 | $99.28 | 1 | Novo Nordisk Inc ($99.28) |
All Payment Transactions
5 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 03/29/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological) | Food and Beverage | In-kind items and services | $16.53 | General |
| Category: VACCINES | ||||||
| 05/11/2023 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $124.46 | General |
| Category: Obesity | ||||||
| 05/12/2022 | Novo Nordisk Inc | Saxenda (Drug) | Food and Beverage | In-kind items and services | $121.06 | General |
| Category: Obesity | ||||||
| 03/31/2022 | Novo Nordisk Inc | Saxenda (Drug) | Food and Beverage | In-kind items and services | $116.61 | General |
| Category: Obesity | ||||||
| 06/17/2021 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $99.28 | General |
| Category: Obesity | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 19 | 626 | 867 | $129,562 | $39,068 |
| 2022 | 13 | 499 | 549 | $81,981 | $34,448 |
| 2021 | 8 | 315 | 333 | $43,644 | $22,667 |
| 2020 | 10 | 307 | 322 | $47,605 | $19,700 |
All Medicare Procedures & Services
50 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 114 | 134 | $42,880 | $12,959 | 30.2% |
| 0241U | Respiratory infectious agent detection by rna for severe acute respiratory syndrome coronavirus 2 (covid 19), influenza a, influenza b, and respiratory syncytial virus, upper respiratory specimen, each reported as detected or not detected | Office | 2023 | 60 | 61 | $15,250 | $8,527 | 55.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 99 | 103 | $32,960 | $5,992 | 18.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 32 | 32 | $10,240 | $3,952 | 38.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 20 | 21 | $6,720 | $2,701 | 40.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 39 | 39 | $12,480 | $2,680 | 21.5% |
| 87880 | Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) | Office | 2023 | 40 | 42 | $1,488 | $680.40 | 45.7% |
| 71046 | X-ray of chest, 2 views | Office | 2023 | 20 | 22 | $1,980 | $372.58 | 18.8% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 24 | 27 | $1,399 | $289.90 | 20.7% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 23 | 23 | $437.00 | $193.20 | 44.2% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 17 | 17 | $629.00 | $175.95 | 28.0% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 14 | 14 | $952.00 | $148.59 | 15.6% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 15 | 15 | $345.00 | $114.15 | 33.1% |
| 94640 | Inhalation treatment for airway obstruction or sputum production | Office | 2023 | 16 | 16 | $691.00 | $107.40 | 15.5% |
| 81001 | Manual urinalysis test with examination using microscope, automated | Office | 2023 | 18 | 19 | $190.00 | $59.09 | 31.1% |
| 81015 | Urinalysis using microscope | Office | 2023 | 15 | 17 | $153.00 | $50.83 | 33.2% |
| 81003 | Automated urinalysis test | Office | 2023 | 21 | 21 | $168.00 | $46.20 | 27.5% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2023 | 20 | 188 | $376.00 | $17.33 | 4.6% |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | Office | 2023 | 19 | 56 | $224.00 | $1.31 | 0.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 138 | 151 | $25,400 | $10,197 | 40.1% |
| 0241U | Respiratory infectious agent detection by rna for severe acute respiratory syndrome coronavirus 2 (covid 19), influenza a, influenza b, and respiratory syncytial virus, upper respiratory specimen, each reported as detected or not detected | Office | 2022 | 69 | 72 | $18,000 | $10,120 | 56.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 67 | 67 | $16,701 | $7,018 | 42.0% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 46 | 46 | $11,321 | $3,047 | 26.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 16 | 16 | $4,960 | $2,351 | 47.4% |
| 87880 | Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) | Office | 2022 | 59 | 61 | $1,952 | $994.88 | 51.0% |
About Dr. Hillery Bavani, D.O
Dr. Hillery Bavani, D.O is a Family Medicine healthcare provider based in Dacula, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/09/2014. The National Provider Identifier (NPI) number assigned to this provider is 1487073110.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Hillery Bavani, D.O has received a total of $477.94 in payments from pharmaceutical and medical device companies, with $16.53 received in 2024. These payments were reported across 5 transactions from 2 companies. The most common payment nature is "Food and Beverage" ($477.94).
As a Medicare-enrolled provider, Bavani has provided services to 1,747 Medicare beneficiaries, totaling 2,071 services with total Medicare billing of $115,884. Data is available for 4 years (2020–2023), covering 50 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Other Specialties Hospitalist, Family Medicine
- Location Dacula, GA
- Active Since 04/09/2014
- Last Updated 05/04/2021
- Taxonomy Code 207Q00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1487073110
Products in Payments
- Saxenda (Drug) $237.67
- Wegovy (Drug) $223.74
- SHINGRIX (Biological) $16.53
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Dacula
Dr. Inchol Yun
Family Medicine — Payments: $15,022
Sumathi Puttu, Md, MD
Family Medicine — Payments: $10,611
Dr. Carla Price, M.d, M.D
Family Medicine — Payments: $4,635
Rene Latoni, Md, MD
Family Medicine — Payments: $2,065
David Najjar, M.d, M.D
Family Medicine — Payments: $1,859
Henry Moon, Md, MD
Family Medicine — Payments: $1,754